ExcelFin Acquisition Corp. (XFIN)

NASDAQ: XFIN · IEX Real-Time Price · USD
10.95
-0.03 (-0.27%)
At close: Apr 18, 2024, 3:59 PM
11.00
+0.05 (0.46%)
After-hours: Apr 18, 2024, 4:00 PM EDT
Market Cap 87.07M
Revenue (ttm) n/a
Net Income (ttm) 2.58M
Shares Out 7.95M
EPS (ttm) 0.08
PE Ratio 137.25
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,112
Open 10.95
Previous Close 10.98
Day's Range 10.95 - 10.95
52-Week Range 10.24 - 11.00
Beta 0.00
Analysts n/a
Price Target n/a
Earnings Date n/a

About XFIN

ExcelFin Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Fort Mill, South Carolina. ExcelFin Acquisition Corp. is a subsidiary of ExcelFin SPAC LLC. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Oct 21, 2021
Employees 4
Stock Exchange NASDAQ
Ticker Symbol XFIN
Full Company Profile

Financial Performance

Financial Statements

News

Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders

Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a $12.50 trading price Minimum cash condition of $15 million has been waived, cementing certainty a...

5 weeks ago - PRNewsWire

ExcelFin Acquisition Corp. Announces Adjournment of Special Meeting

NEW YORK, Oct. 17, 2023 /PRNewswire/ -- ExcelFin Acquisition Corp. ("we", "us", "our", or the "Company"), today announced that the Special Meeting originally scheduled for October 18, 2023 (the "Speci...

6 months ago - PRNewsWire

Baird Medical, A Leading Developer and Provider of Microwave Ablation (MWA) Medical Devices in China, to be Publicly Listed on NASDAQ through a Proposed Business Combination with ExcelFin Acquisition Corp.

Ranked first among MWA medical device providers in thyroid nodule and breast lump treatment with approximately 35% market share in China [1] Extensive distribution network with over 430 hospitals pene...

10 months ago - PRNewsWire

ExcelFin Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing December 13, 2021

SAN FRANCISCO, Dec. 15, 2021 /PRNewswire/ -- ExcelFin Acquisition Corp. (Nasdaq: XFIN) (the "Company") announced today that commencing December 13, 2021, holders of the units sold in the Company's ini...

2 years ago - PRNewsWire